Laura C Rosella1, Michael Lebenbaum2, Tiffany Fitzpatrick2, Aleksandra Zuk3, Gillian L Booth4. 1. Dalla Lana School of Public Health, Toronto, Ontario, Canada Public Health Ontario, Toronto, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada laura.rosella@utoronto.ca. 2. Public Health Ontario, Toronto, Ontario, Canada. 3. Dalla Lana School of Public Health, Toronto, Ontario, Canada. 4. St. Michael's Hospital, Toronto, Ontario, Canada Institute of Health Management Policy and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Abstract
OBJECTIVE: To provide the first population-based estimates of prediabetes and undiagnosed type 2 diabetes prevalence in Canada. RESEARCH DESIGN AND METHODS: We combined two fasting subsamples of the Canadian Health Measures Survey, which were restricted to nonpregnant adults ≥20 years of age (N = 3,494). Undiagnosed diabetes was defined as not having self-reported type 2 diabetes but having blood glucose measures that met Canadian guidelines (i.e., fasting plasma glucose [FPG] level of ≥7.0 mmol/L or hemoglobin A1c [HbA1c] level of ≥6.5% [≥48 mmol/mol]). Prediabetes was defined as an FPG level of ≥6.1 and <7.0 mmol/L or an HbA1c level of ≥6.0% and <6.5% (≥42 and <48 mmol/mol). All estimates were weighted using survey sampling weights. CIs were calculated with the bootstrap method. RESULTS: According to FPG levels, the prevalence of undiagnosed type 2 diabetes in Canadian adults was 1.13% (95% CI 0.79, 1.62), contributing to ∼20% of total type 2 diabetes prevalence (5.62 [95% CI 4.52, 6.95]). Compared with FPG levels, the undiagnosed prevalence was greater using HbA1c level as a criterion (3.09% [95% CI 1.97, 4.81]), ∼41% of the total number of cases of diabetes (7.55 [95% CI 5.98, 9.49]). The HbA1c-only criterion resulted in a threefold increase in prediabetes prevalence overall and a sixfold increase among females (FPG 2.22%, HbA1c 13.31%). Screening based on FPG only identified older undiagnosed case patients, with a mean age of 58.7 years (95% CI 59.9, 63.4). Similarly, using HbA1c identified younger individuals with prediabetes, with reduced BMI and waist circumference compared with FPG levels. CONCLUSIONS: In this first study of a nationally representative sample with biospecimen measures, we found that the prevalence of undiagnosed type 2 diabetes and prediabetes was significantly higher using HbA1c levels compared with FPG levels. Further evaluation is needed to fully assess the impact of using the HbA1c criterion.
OBJECTIVE: To provide the first population-based estimates of prediabetes and undiagnosed type 2 diabetes prevalence in Canada. RESEARCH DESIGN AND METHODS: We combined two fasting subsamples of the Canadian Health Measures Survey, which were restricted to nonpregnant adults ≥20 years of age (N = 3,494). Undiagnosed diabetes was defined as not having self-reported type 2 diabetes but having blood glucose measures that met Canadian guidelines (i.e., fasting plasma glucose [FPG] level of ≥7.0 mmol/L or hemoglobin A1c [HbA1c] level of ≥6.5% [≥48 mmol/mol]). Prediabetes was defined as an FPG level of ≥6.1 and <7.0 mmol/L or an HbA1c level of ≥6.0% and <6.5% (≥42 and <48 mmol/mol). All estimates were weighted using survey sampling weights. CIs were calculated with the bootstrap method. RESULTS: According to FPG levels, the prevalence of undiagnosed type 2 diabetes in Canadian adults was 1.13% (95% CI 0.79, 1.62), contributing to ∼20% of total type 2 diabetes prevalence (5.62 [95% CI 4.52, 6.95]). Compared with FPG levels, the undiagnosed prevalence was greater using HbA1c level as a criterion (3.09% [95% CI 1.97, 4.81]), ∼41% of the total number of cases of diabetes (7.55 [95% CI 5.98, 9.49]). The HbA1c-only criterion resulted in a threefold increase in prediabetes prevalence overall and a sixfold increase among females (FPG 2.22%, HbA1c 13.31%). Screening based on FPG only identified older undiagnosed case patients, with a mean age of 58.7 years (95% CI 59.9, 63.4). Similarly, using HbA1c identified younger individuals with prediabetes, with reduced BMI and waist circumference compared with FPG levels. CONCLUSIONS: In this first study of a nationally representative sample with biospecimen measures, we found that the prevalence of undiagnosed type 2 diabetes and prediabetes was significantly higher using HbA1c levels compared with FPG levels. Further evaluation is needed to fully assess the impact of using the HbA1c criterion.
Authors: Kevin Phan; Paul Mitchell; Gerald Liew; Adam J Plant; Sarah B Wang; Joshua Xu; Joseph Chiha; Aravinda Thiagalingam; George Burlutsky; Bamini Gopinath Journal: J Thorac Dis Date: 2016-07 Impact factor: 2.895
Authors: Mohammad M H Abdullah; Christopher P F Marinangeli; Peter J H Jones; Jared G Carlberg Journal: Nutrients Date: 2017-07-22 Impact factor: 5.717
Authors: Maysm N Mohamad; Leila Cheikh Ismail; Lily Stojanovska; Vasso Apostolopoulos; Jack Feehan; Amjad H Jarrar; Ayesha S Al Dhaheri Journal: PLoS One Date: 2021-06-17 Impact factor: 3.240
Authors: Eva Graham; Tristan Watson; Sonya S Deschênes; Kristian B Filion; Mélanie Henderson; Sam Harper; Laura C Rosella; Norbert Schmitz Journal: Sci Rep Date: 2021-06-30 Impact factor: 4.379
Authors: Kate Junker; Claire M Buckley; Seán R Millar; Sinéad Flynn; Janas M Harrington; Patricia M Kearney; Ivan J Perry Journal: PLoS One Date: 2021-06-25 Impact factor: 3.240